---
figid: PMC1383661__bic258i003
figlink: /pmc/articles/PMC1383661/figure/F3/
number: F3
caption: PDE4-inhibitor-induced apoptosis in B-CLL cells appears to occur by a PKA-mediated
  pathway, as the percentage of cells that undergo apoptosis following rolipram treatment
  is reduced by co-treatment with the PKA antagonist Rp-8-Br-cAMPS. In contrast, activation
  of the cAMP effector EPAC1 by the EPAC-specific agonist 8-CPT-2Me-cAMP is anti-apoptotic
  in B-CLL cells. As the net effect of PDE4 inhibitor treatment is to induce apoptosis
  in B-CLL cells, the pro-apoptotic PKA-mediated pathway appears to predominate over
  the anti-apoptotic effects of PDE4-inhibitor-mediated EPAC activation. One study
  reported that PKA signalling induces apoptosis in B-CLL cells by activating PP2A,
  which in turn dephosphorylates BAD, releasing it from 14-3-3 proteins, and allowing
  BAD to initiate apoptosis through a mitochondrial pathway. Cyt C, cytochrome c.
pmcid: PMC1383661
papertitle: Cyclic nucleotide phosphodiesterases as targets for treatment of haematological
  malignancies.
reftext: Adam Lerner, et al. Biochem J. 2006 Jan 1;393(Pt 1):21-41.
pmc_ranked_result_index: '58832'
pathway_score: 0.9785034
filename: bic258i003.jpg
figtitle: Cyclic nucleotide phosphodiesterases as targets for treatment of haematological
  malignancies
year: '2006'
organisms:
- Homo sapiens
ndex: 9d7d96df-debd-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC1383661__bic258i003.html
  '@type': Dataset
  description: PDE4-inhibitor-induced apoptosis in B-CLL cells appears to occur by
    a PKA-mediated pathway, as the percentage of cells that undergo apoptosis following
    rolipram treatment is reduced by co-treatment with the PKA antagonist Rp-8-Br-cAMPS.
    In contrast, activation of the cAMP effector EPAC1 by the EPAC-specific agonist
    8-CPT-2Me-cAMP is anti-apoptotic in B-CLL cells. As the net effect of PDE4 inhibitor
    treatment is to induce apoptosis in B-CLL cells, the pro-apoptotic PKA-mediated
    pathway appears to predominate over the anti-apoptotic effects of PDE4-inhibitor-mediated
    EPAC activation. One study reported that PKA signalling induces apoptosis in B-CLL
    cells by activating PP2A, which in turn dephosphorylates BAD, releasing it from
    14-3-3 proteins, and allowing BAD to initiate apoptosis through a mitochondrial
    pathway. Cyt C, cytochrome c.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CASP5
  - PRKACG
  - CASP1
  - CASP2
  - PRKACA
  - CASP14
  - CASP3
  - PRKACB
  - CASP10
  - PDE4C
  - PRKAR1A
  - PDE4D
  - PDE4B
  - CASP9
  - CASP12
  - PRKAR1B
  - RAPGEF3
  - PDE4A
  - CASP8
  - PRKAR2A
  - CASP6
  - CASP7
  - CASP4
  - BAD
  - APAF1
  - TERF2IP
  - PRKAR2B
  - YWHAQ
  - Rolipram
genes:
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: PDE4
  symbol: PDE4
  source: bioentities_symbol
  hgnc_symbol: PDE4C
  entrez: '5143'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: PDE4
  symbol: PDE4
  source: bioentities_symbol
  hgnc_symbol: PDE4D
  entrez: '5144'
- word: PDE4
  symbol: PDE4
  source: bioentities_symbol
  hgnc_symbol: PDE4B
  entrez: '5142'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: EPAC
  symbol: EPAC
  source: hgnc_alias_symbol
  hgnc_symbol: RAPGEF3
  entrez: '10411'
- word: PDE4
  symbol: PDE4
  source: bioentities_symbol
  hgnc_symbol: PDE4A
  entrez: '5141'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: BÃ…D
  symbol: BAD
  source: hgnc_symbol
  hgnc_symbol: BAD
  entrez: '572'
- word: CytC/APAF-1
  symbol: APAF-1
  source: hgnc_alias_symbol
  hgnc_symbol: APAF1
  entrez: '317'
- word: Rap1
  symbol: RAP1
  source: hgnc_alias_symbol
  hgnc_symbol: TERF2IP
  entrez: '54386'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: 14-3-3
  symbol: 14-3-3
  source: hgnc_alias_symbol
  hgnc_symbol: YWHAQ
  entrez: '10971'
chemicals:
- word: Rolipram
  source: MESH
  identifier: D020889
diseases: []
figid_alias: PMC1383661__F3
redirect_from: /figures/PMC1383661__F3
figtype: Figure
---
